Download PHS 398 (Rev. 9/04), Biographical Sketch Format

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts

Blood–brain barrier wikipedia , lookup

Psychopharmacology wikipedia , lookup

Neuropharmacology wikipedia , lookup

Neuropsychopharmacology wikipedia , lookup

Transcript
Principal Investigator/Program Director (Last, First, Middle):
BIOGRAPHICAL SKETCH
Provide the following information for the key personnel and other significant contributors in the order listed on Form Page 2.
Follow this format for each person. DO NOT EXCEED FOUR PAGES.
NAME
POSITION TITLE
Steven M. Berman
Researcher II
eRA COMMONS USER NAME
EDUCATION/TRAINING (Begin with baccalaureate or other initial professional education, such as nursing, and include postdoctoral training.)
INSTITUTION AND LOCATION
DEGREE
(if applicable)
YEAR(s)
FIELD OF STUDY
Wayne State University, Detroit, MI
B.S.
1971
Psychology (Honors)
City University of New York, New York, NY
M.Ph.
1986
Psychology
City University of New York, New York, NY
Ph.D.
1986
Experimental Cognition
A. Positions and Honors.
Positions and Employment
1990 – Present Assistant-Full Researcher, Neuropsychiatric Institute, UCLA
1994 – 1995
Adjunct Lecturer, Psychology Department, California State University, Northridge
1994 – 1999
Assistant-Associate Researcher, Physics Department, UC Irvine
1994 – Present Assistant-Full Researcher, Nuclear Medicine, Greater LA VA Healthcare System
1996 – 1999
Assistant-Associate Researcher, Psychology Department, UCLA
1998 – Present Associate-Full Researcher, Department of Medicine, UCLA
1999 – 2000
Adjunct Lecturer, Psychology Department, Pepperdine University Graduate School
1999 – 2004
Associate Researcher, Brain Imaging, Long Beach VA Medical Center
Other Experience and Professional Memberships
1990 – Present Ad hoc reviewer: Alcohol, Int J Psychophysiol, Psychophysiology, Neuroimage, others
Member: Soc. for Neuroscience, Soc. Pschophysiol. Res., UCLA Brain Research Institute
B. Selected peer-reviewed publications (in chronological order).
1. Berman S, Friedman D, Cramer M. A developmental study of Event-Related Potentials to pictures and
words during explicit and implicit memory. Int J Psychophysiol 1990;10:191-197.
2. Friedman D, Putnam L, Hamberger M, Berman S. Mini-longitudinal study of the cognitive ERPs during
picture matching in children, adolescents and adults: A replication. J Psychophysiology 1992;6:29-46.
3. Berman S, Whipple S, Fitch R, Noble E. P3 in young boys as a predictor of adolescent substance use.
Alcohol 1992;10:69-76.
4. Friedman D, Berman S, Hamberger M. Recognition memory and ERPs: Age-related changes in young,
middle-aged and elderly adults. J Psychophysiology 1993;7:181-201.
5. Berman S, Friedman D. A developmental study of ERPs during recognition memory: Effects of picture
familiarity, word frequency and readability. J Psychophysiology 1993;7:97-114.
6. Berman S, Martinez R, Noble E. Familial alcoholism and ERPs: Differences in probability sensitivity?
Alcohol Alcohol 1993;28:695-707.
7. Berman S, Noble E. Childhood antecedents of substance misuse. Curr Opin Psychiatry 1993;6:382-387.
8. Noble EP, Berman S, Ozkaragoz TZ, Ritchie T. Prolonged P300 latency in children with the D2 dopamine
receptor A1 allele. Am J Hum Genet 1994;54:658-668.
9. Berman S, Noble E. Reduced visuospatial performance in children with the D2 dopamine receptor A1
allele. Behav Genet 1995;25:45-58.
10. Berman S, Friedman D. The developmental of selective attention as reflected by event-related brain
potentials. J Exp Child Psychol 1995;59:1-31.
11. Berman S. ERP signs of distractability and selectivity in children. Electroencephalogr Clin Neurophysiol
Suppl 1995;44:326-333.
12. Berman S, Noble E. D2 dopamine receptor (DRD2) gene and family stress: Interactive effects on cognitive
function in children. Behav Genet 1997;27:33-43.
PHS 398/2590 (Rev. 09/04, Reissued 4/2006)
Page
Biographical Sketch Format Page
Principal Investigator/Program Director (Last, First, Middle):
13. Berman S, Munakata J, Naliboff BD, Chang L, Mandelkern M, Silverman D, Kovalik E, Mayer EA. Gender
differences in regional brain response to visceral pressure in IBS patients. Eur J Pain 2000;4:157-72.
14. Naliboff BD, Derbyshire SW, Munakata J, Berman S, Mandelkern M, Chang L, Mayer EA. Cerebral
activation in patients with irritable bowel syndrome and control subjects during rectosigmoid stimulation.
Psychosom Med 2001;63:365-75.
15. Mayer EA, Berman S, Derbyshire SW, Suyenobu B, Chang L, Fitzgerald L, Mandelkern M, Hamm L, Vogt
B, Naliboff BD. The effect of the 5-HT3 receptor antagonist, alosetron, on brain responses to visceral
stimulation in irritable bowel syndrome patients. Aliment Pharmacol Ther 2002;16:1357-66.
16. Berman SM, Chang L, Suyenobu B, Derbyshire SW, Stains J, Fitzgerald L, Mandelkern M, Hamm L, Vogt
B, Naliboff BD, Mayer EA. Condition-specific deactivation of brain regions by 5-HT3 receptor antagonist
Alosetron. Gastroenterology 2002;123:969-77.
17. Berman SM, Naliboff BD, Chang L, Fitzgerald L, Antolin T, Camplone A, Mayer EA. Enhanced preattentive
central nervous system reactivity in irritable bowel syndrome. Am J Gastroenterol 2002;97:2791-7.
18. Berman SM, Ozkaragoz T, Noble E. D2 Dopamine Receptor Gene Polymorphism Discriminates
Two Kinds of Novelty Seeking. Personality and Individual Differences, 33, 2002, 867-882.
19. Naliboff BD, Berman S, Chang L, Derbyshire SW, Suyenobu B, Vogt BA, Mandelkern M, Mayer EA. Sexrelated differences in IBS patients: central processing of visceral stimuli. Gastroenterol 2003;124:1738-47.
20. Berman SM, Mandelkern MA, Phan H, Zaidel E. Complementary hemispheric specialization for word and
accent detection. Neuroimage 2003;19:319-331.
21. Chang L, Berman S, Mayer EA, Suyenobu B, Derbyshire S, Naliboff B, Vogt B, FitzGerald L, Mandelkern
MA. Brain responses to visceral and somatic stimuli in patients with irritable bowel syndrome with and
without fibromyalgia. Am J Gastroenterol 2003;98:1354-61.
22. Berman SM. The use of event-related potentials for measuring interhemispheric transfer time. In: Zaidel E,
Iacoboni M (Eds.), The Parallel Brain, Cambridge, MA: MIT Press, 2003 pp 230.
23. Berman SM, Ozkaragoz T, Noble EP, Antolin T, Sheen C, Siddarth P, Conner BT, Ritchie T. Differential
associations of gender and D2 dopamine receptor (DRD2) genotype with negative affect and other
substance abuse markers in children of alcoholics. Alcohol 2003;30:201-10.
24. Lieberman MD, Jarcho JM, Berman S, Naliboff BD, Suyenobu BY, Mandelkern M, Mayer EA. The neural
correlates of placebo effects: a disruption account. Neuroimage 2004;22:447-55.
25. Mayer EA, Berman S, Chang L, Naliboff BD. Sex-based differences in gastrointestinal pain. Eur J Pain
2004;8:451-63.
26. Rotheram-Fuller E, Shoptaw S, Berman SM, London ED. Impaired performance in a test of decisionmaking by opiate-dependent tobacco smokers. Drug Alcohol Depend 2004;73:79-86.
27. London ED, Simon SL, Berman SM, Mandelkern MA, Lichtman AM, Bramen J, Shinn AK, Miotto K, Learn
J, Dong Y, Matochik JA, Kurian V, Newton T, Woods R, Rawson R, Ling W. Mood disturbances and
regional cerebral metabolic abnormalities in recently abstinent methamphetamine abusers. Arch Gen
Psychiatry 2004;61:73-84.
28. Weems SA, Zaidel E, Berman S, Mandelkern MA. Asymmetry in alpha power predicts accuracy of
hemispheric lexical decision. Clin Neurophysiol 2004;115:1575-82.
29. Mayer EA, Berman S, Suyenobu B, Labus J, Mandelkern MA, Naliboff BD, Chang L. Differences in brain
responses to visceral pain between patients with irritable bowel syndrome and ulcerative colitis. Pain
2005;115:398-409.
30. Bauer M, London ED, Rasgon N, Berman SM, Frye MA, Altshuler LL, Mandelkern MA, Bramen J, Voytek
B, Woods R, Mazziotta JC, Whybrow PC. Supraphysiological doses of levothyroxine alter regional cerebral
metabolism and improve mood in bipolar depression. Mol Psychiatry 2005;10:456-69.
31. Voytek B, Berman SM, Hassid BD, Simon SL, Mandelkern MA, Brody AL, Monterosso J, Ling W, London
ED. Differences in regional brain metabolism associated with marijuana abuse in methamphetamine
abusers. Synapse 2005;57:113-5.
32. Conner BT, Noble EP, Berman SM, Ozkaragoz T, Ritchie T, Antolin T, Sheen C. DRD2 genotypes and
substance use in adolescent children of alcoholics. Drug Alcohol Depend 2005;79:379-87.
33. London ED, Berman SM, Voytek B, Simon SL, Mandelkern MA, Monterosso J, Thompson PM, Brody AL,
Geaga JA, Hong MS, Hayashi KM, Rawson RA, Ling W. Cerebral metabolic dysfunction and impaired
vigilance in recently abstinent methamphetamine abusers. Biol Psychiatry 2005;58:770-8.
PHS 398/2590 (Rev. 09/04, Reissued 4/2006)
Page
Continuation Format Page
Principal Investigator/Program Director (Last, First, Middle):
34. Berman SM, Noble EP, Antolin T, Sheen C, Conner BT, Ritchie T. P300 development during adolescence:
effects of DRD2 genotype. Clin Neurophysiol 2006;117:649-59.
35. Berman SM, Naliboff BD, Suyenobu B, Labus JS, Stains J, Bueller JA, Ruby K, Mayer EA. Sex differences
in regional brain response to aversive pelvic visceral stimuli. Am J Physiol Regul Integr Comp Physiol 2006
Apr 13; [Epub ahead of print] PMID: 16614061.
C. Research Support
Ongoing Research Support
R01 DK48351 Mayer (PI)
07/01/01 – 05/31/06 (no cost extension to 03/31/07)
NIH
Perception and Modulation of Visceral Sensations
The major goals of this project are: 1) Compare rectal sensitivity in patients with IBS, inflammatory bowel
disease and controls; 2) Compare rectal and esophageal sensitivity in IBS patients; 3) Using brain imaging,
examine the regions associated with rectal and esophageal stimulation in patients with IBS, inflammatory
bowel disease, and controls; 4) Examine opioid mechanisms of visceral sensitivity using naloxone challenge.
Role: Responsible for design, execution and analysis of functional brain imaging component
P50 DK64539-01 Mayer (PI)
09/30/02 – 08/31/07
NIH
Sex Differences in Central Stress Circuit Responsiveness in IBS and IC Patients
The goals of this project are: 1) To identify factors which underlie the greater vulnerability of women to develop
a range of stress-related chronic pain disorders. 2) To determine sex-related differences in the responsiveness
of central stress circuits in terms of HPA axis, autonomic output and pain modulation in healthy control
subjects, patients with IBS and patients with interstitial cystitis.
Role: Responsible for design, execution and analysis of functional brain imaging and ERP components.
Completed Research Support
R01 AR46122-01 Chang (PI)
07/01/99 – 06/30/04
NIH
Neuroendocrine Alterations in Fibromyalgia and IBS
This study has the goal of comparing perceptual, neuroendocrine, autonomic, and CNS responses in irritable
bowel syndrome and fibromyalgia.
Role: Responsible for design, execution and analysis of functional brain imaging component
NIH/NINR NR04881-03 Naliboff (PI)
08/15/98 – 07/31/01
Gender Related Differences in Visceral Sensitivity
The major goals of this project are: 1) Compare symptoms, visceral sensitivity and regional brain activation
using PET and fMRI in male and female patients with IBS; 2) Compare symptoms, visceral sensitivity and
regional brain activation in female patients with IBS at two time points during their menstrual cycle.
Role: Responsible for design, execution and analysis of functional brain imaging component
5 R01 AA11573 Noble (PI)
09/01/97 – 08/31/02
NIH/NIAAA
CNS and Genetic Markers in Children of Alcoholics
A developmental study of risk and protective factors for alcohol/drug abuse in 200 children of alcoholics.
Role: Co-PI with primary responsibility for electrophysiological component
14278 Mayer (PI)
01/01/97 – 06/30/03
AstraZeneca
Basic and Clinical Studies in Functional GI Disorders
The major goals of this program are to develop new pharmacological treatments for functional digestive
diseases. Specific research projects address: 1) development of techniques for visceral sensitivity testing in
rats, mice and humans; 2) examination of potential treatment compounds in animal models; 3) cellular and
molecular mechanisms of visceral sensation; and 4) human trials.
Role: Responsible for design, execution and analysis of functional brain imaging components
PHS 398/2590 (Rev. 09/04, Reissued 4/2006)
Page
Continuation Format Page